Basic Research & Discovery
We conduct hypothesis-driven research to decode the biological mechanisms underlying disease. By integrating experimental biology, chemistry, and data science, we generate high-resolution insights that inform strategic decision-making and fuel translational progress.
Advancing foundational science to identify, validate, and prioritize therapeutic and diagnostic targets.
Our discovery engine integrates advanced laboratory platforms, computational biology, and systems-level analysis to uncover the molecular drivers of disease and translate biological insight into actionable innovation.
-
We operate fully integrated laboratory platforms equipped with high-precision instrumentation and automated workflows. Robotic liquid handling, automated cell culture systems, and high-content screening technologies enable reproducible, scalable experimentation while accelerating discovery timelines.
-
Our molecular biology capabilities support gene editing, gene expression analysis, pathway interrogation, and protein engineering. Using CRISPR systems, transcriptomic profiling, and functional assays, we define mechanistic pathways and establish causal links between targets and disease phenotypes.
-
Our bioinformatics infrastructure transforms complex biological datasets into structured insights. We develop analytical pipelines for genomic sequencing, transcriptomic analysis, variant interpretation, and pathway modeling to guide hypothesis generation and target prioritization.
-
We leverage multi-omics technologies including genomics, proteomics, metabolomics, and epigenomics to generate comprehensive molecular profiles. Integrated omics analyses allow us to map disease networks and identify biomarkers for stratification and therapeutic response.
-
Advanced imaging modalities including high-content microscopy, live-cell imaging, and molecular imaging enable real-time visualization of cellular and tissue-level processes. These platforms provide phenotypic validation of mechanistic hypotheses.
-
Through systems biology, functional genomics, and computational modeling, we identify and validate novel therapeutic targets. Our target discovery framework integrates biological evidence, translational feasibility, and clinical relevance to prioritize candidates with high development potential.